Healthcare Knuggets
Jan 07, 2024
In today’s news, researchers have found that GLP-1 drugs used to treat type 2 diabetes do not raise a person’s risk of pancreatic cancer, which is great news for individuals managing diabetes. Additionally, there’s promising information on protecting against cognitive decline, with researchers identifying factors that may help protect against cognitive decline, such as regular exercise, a Mediterranean-style diet, getting enough sleep, engaging in mental stimulation, and maintaining strong social connections.
In the realm of rare diseases, there’s a spotlight on the latest advances in rare disease research and therapeutics, with a new e-book from STAT compiling articles that bring attention to critical issues facing the rare disease community and today’s advances. Finally, the latest cholesterol guidelines reveal a shift towards a highly personalized approach to cholesterol medications, providing more tailored treatment options and recommendations based on specific health needs.
Overall, today’s news brings a wealth of information that empowers individuals to take charge of their health and well-being. Stay informed, stay positive, and stay healthy!
Summy
Stay Well!Don’t miss an exclusive pairing of STAT articles covering new
research and therapeutics on rare dis…
Protecting against cognitive decline
Ozempic, Wegovy, other GLP-1RA drugs not linked to increased
pancreatic cancer risk, study finds
